#	Pagina
attuale pagina	/open-h2020/projects/196508/index.html

Opendata, web and dolomites

PCMPS

Precision Cancer Medicine Pipeline and Services

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

PCMPS project word cloud

Explore the words cloud of the PCMPS project. It provides you a very rough idea of what is the project "PCMPS" about.

treatments suite treatment miss nevertheless accomplishment benefits suffer biggest streamline forcing generation drivers sequencing turnover 25 validate staggering treating beneficiaries personalized patient annual positions million intolerable outcomes strain time market opportunity pursue life ineffective medicine 30 population health clinical pcmps commercialization enter 2009 pipeline 2010 money spent precision toll patients pmcps providers beneficiary waste tools expand cancer 124 business complete start head expectancy pubgene is aging give despite prescribing put markets services western therapy billion efficacious governments 17 harsh 126 hit payers longer receive worldwide doctors world solutions

Project "PCMPS" data sheet

The following table provides information about the project.

Coordinator	PUBGENE AS Organization address address: SOGNSVEIEN 70A city: OSLO postcode: 855 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Norway [NO]
Project website	http://www.pubgene.com
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)) 2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
Code Call	H2020-SMEINST-1-2014
Funding Scheme	SME-1
Starting year	2015
Duration (year-month-day)	from 2015-05-01 to 2015-10-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	PUBGENE AS PUBGENE AS Organization address address: SOGNSVEIEN 70A city: OSLO postcode: 855 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	NO (OSLO)	coordinator	50˙000.00

Map

Project objective

'Cancer cost the EU €126 billion in 2009, while in 2010 the US spent a staggering $124.6 billion on treating cancer. This cost is set to rise as the effects of an aging population and increasing life expectancy take their toll. These market drivers will put an intolerable strain on health services across the western world, forcing governments to streamline their health services. Current cancer treatment is based on the 'average cancer patient', meaning some cancer patients may not respond to the treatment while others do. Thus it is clearly is a need for solutions that offer precision cancer medicine.

PubGene AS aims to pursue a major market opportunity by developing a complete pipeline for precision cancer medicine (PCMPS), that include the necessary steps from Next Generation Sequencing to clinical treatment support for cancer patients. The biggest beneficiary of PCMPS will be the patient, who will receive a personalized treatment rather than a “hit and miss” approach to therapy. This will improve patient outcomes and ensure patients no longer have to suffer harsh side effects from non-efficacious treatments. The second beneficiaries will be the health providers and payers, as doctors will no longer waste time and money prescribing ineffective treatments. Nevertheless, despite the benefits of personalized cancer medicine, it is crucial to validate and demonstrate the benefits of this type of cancer medicine before large-scale commercialization.

PMCPS is an opportunity for PubGene to expand our suite of applications and enter into complete new market for PubGene - targeting the treatment market. The project will give us a head start in providing tools in the field of personalized cancer medicine, ensuring us strong positions in the future European and worldwide markets. Accomplishment of the project will represent a significant business opportunity with an expected annual turnover of €17 million with a 25-30% annual increase, 3 years after commercialization. '

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PCMPS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PCMPS" are provided by the European Opendata Portal: CORDIS opendata.